封面
市场调查报告书
商品编码
1373760

全球脑植入市场 - 市场规模、份额和成长分析:按类型、应用和最终用户 - 行业预测(2023-2030)

Global Brain Implant Market Size, Share, Growth Analysis, By Type(Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).), By Application(Parkinson's disease, epilepsy), By End user(Hospitals, neurology clinics) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2021年全球脑植入市场规模为12.5亿美元,2022年为14亿美元。预计该市场在预测期(2023-2030年)将以12.2%的年复合成长率成长,到2030年将达到35.2亿美元。

在技​​术进步和神经系统疾病盛行率上升的推动下,全球脑植入市场正在稳步成长。脑植入物,也称为神经植入物或神经假体,是一种与大脑连接以诊断、监测和治疗各种神经系统疾病的植入式医疗设备。脑植入物的应用范围从癫痫管理和帕金森氏症治疗到认知增强和脑机接口,提供了一种有前途的治疗选择。市场上的主要参与企业,包括美敦力(Medtronic)、雅培实验室(Abbott Laboratories)和波士顿科学公司(Boston Scientific),正在投资研发以推进脑植入技术。小型化、改进的电极设计以及与人工智慧演算法的整合技术进步正在提高大脑植入物的有效性和安全性。然而,随着该领域的不断发展,需要解决围绕大脑植入的伦理和隐私考虑,例如知情同意和资料保护。

帕金森氏症、癫痫和慢性疼痛等神经系统疾病的罹患率和盛行率不断上升,推动了对脑植入技术的需求。这些植入物为控制症状和改善患者的生活品质提供了有效的治疗选择。

全球脑植入市场的主要市场趋势之一是日益关注植入装置的小型化和无线连接。技术的进步导致了更小、更紧凑的大脑植入物的开发,使外科手术的侵入性更小,并提高了患者的舒适度。微型植入物提供了微创或非侵入性方法的可能性,例如经颅磁刺激(TMS)和非侵入性电刺激。这些进步对于可能受益于长期植入的患者尤其重要,因为小型化装置降低了併发症的风险并且更容易植入和移除。

该报告研究了全球脑植入市场,并提供了市场概述,包括按类型、应用、最终用户、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

母市场分析

市场规模

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

关键市场洞察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 趋势分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 顶级投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
  • 法规状况
  • 波特分析

全球脑植入市场,依类型

  • 市场概况
  • 深部脑部刺激 (DBS) 和迷走神经刺激 (VNS)

全球脑植入物市场(按应用)

  • 市场概况
  • 帕金森氏症
  • 癫痫
  • 其他的

全球脑植入市场,依最终用户划分

  • 市场概况
  • 医院
  • 神经内科门诊
  • 其他的

全球脑植入市场,按地区

  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

竞争形势

  • 主要企业简介
    • Medtronic
    • Abbott Laboratories
    • Boston Scientific Corporation
    • NeuroPace
    • Cochlear Limited
    • LivaNova PLC
    • Stryker Corporation
    • Nevro Corporation
    • NDI Medical
    • Nihon Kohden Corporation
    • Second Sight Medical Products, Inc.
    • Aleva Neurotherapeutics SA
    • Renishaw plc
    • Cyber??onics, Inc.
    • Neuronetics, Inc.
    • Natus Medical Incorporated
    • BrainLab AG
    • St. Jude Medical, Inc.
    • NeuroSigma, Inc.
    • Alpha Omega Engineering
简介目录
Product Code: SQMIG45A2096

Global Brain Implant Market size was valued at USD 1.25 billion in 2021 and is poised to grow from USD 1.4 billion in 2022 to USD 3.52 billion by 2030, at a CAGR of 12.2% during the forecast period (2023-2030).

The global brain implant market has been experiencing steady growth, driven by advancements in technology and a rising prevalence of neurological disorders. Brain implants, also known as neural implants or neuroprosthetics, are implanted medical devices that interface with the brain to diagnose, monitor, and treat various neurological conditions. With applications ranging from epilepsy management and Parkinson's disease treatment to cognitive enhancement and brain-computer interfaces, brain implants offer promising therapeutic options. Key players in the market, including Medtronic, Abbott Laboratories, and Boston Scientific, invest in research and development to advance brain implant technologies. Technological advancements, such as miniaturization, improved electrode designs, and integration with artificial intelligence algorithms, are enhancing the efficacy and safety of brain implants. However, ethical and privacy considerations surrounding brain implants, such as informed consent and data protection, need to be addressed as the field continues to evolve.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brain Implant Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Brain Implant Market Segmental Analysis

The global brain implants market is segmented based on type, application, end user, and region. In terms of type, the market is divided into deep brain stimulation (DBS) and vagus nerve stimulation (VNS). DBS involves the implantation of electrodes to deliver electrical impulses to specific brain areas, while VNS utilizes electrical stimulation of the vagus nerve for neurological treatment. The market is categorized by application into Parkinson's disease, epilepsy, and other conditions. The end users of brain implant devices include hospitals, neurology clinics, and other healthcare settings. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Brain Implant Market

Increasing Prevalence of Neurological Disorders

  • The rising incidence and prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the demand for brain implant technologies. These implants offer effective treatment options for managing symptoms and improving patients' quality of life.

Restraints in the Global Brain Implant Market

Ethical and Privacy Concerns

  • The use of brain implants raises ethical concerns related to informed consent, privacy, and potential misuse of brain data. The invasive nature of brain implant procedures also poses risks and requires careful consideration of the potential benefits and long-term implications for patients.

Market Trends of Global Brain Implant Key

  • One key market trend in the global brain implant market is the increasing focus on miniaturization and wireless connectivity of implantable devices. Advancements in technology have led to the development of smaller, more compact brain implants, reducing the invasiveness of surgical procedures and enhancing patient comfort. Miniaturized implants offer the potential for minimally invasive or even non-invasive approaches, such as transcranial magnetic stimulation (TMS) or non-invasive electrical stimulation techniques. These advancements are particularly important for patients who may benefit from long-term implantation, as smaller devices can reduce the risk of complications and allow for easier implantation and removal.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Brain Implant Market by Type
    • Market Overview
    • Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).
  • Global Brain Implant Market by Application
    • Market Overview
    • Parkinson's disease
    • epilepsy
    • and other conditions
  • Global Brain Implant Market by End user
    • Market Overview
    • Hospitals
    • neurology clinics
    • and other healthcare settings
  • Global Brain Implant Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NeuroPace (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cochlear Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nevro Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NDI Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Second Sight Medical Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Aleva Neurotherapeutics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Renishaw plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cyberonics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Neuronetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BrainLab AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • St. Jude Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • NeuroSigma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Alpha Omega Engineering (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments